|10/27/10||Quidel Reports Third Quarter EPS of ($.21) (Benzinga)|
Quidel Corporation (NASDAQ: QDEL) announced today financial results for its third quarter ended September 30, 2010. Third Quarter 2010 Results For the third quarter of 2010, total revenues were $28.2 million, compared to $56.2 million for the third quarter of 2009, a decrease of 50%. The comparison to the prior year is affected by higher than normal revenues in 2009 due to the H1N1 pandemic. Net loss for the third quarter of 2010 was $5.9 million, or $0.21 per share, compared to net...
|9/29/10||Day Trader's Alert: QDEL, ALNY, GMCR (Stock Wizard)|
Shares of Quidel Corporation (NASDAQ: QDEL), jumped more than 6% after it announced that it has received 510(k) clearance from the United States Food and Drug Administration for the sale of its QuickVue RSV 10, a lateral flow immunoassay test for the qualitative detection of acute respiratory syncytial virus infections. Almost all infants will suffer from an RSV infection before the age of two. According to the United States Centers for Disease Control and Prevention, RSV is the most common...
|3/30/10||Take Advantage of a 43% Upside on this Healthcare Reform Stock Trade (Penny Sleuth)|
With healthcare legislation at the forefront of investors’ minds right now, it’s only natural to expect a short-term rally in the medical supply stocks that are due to see increased sales volume at the hands of a $940 billion government dole. That’s why today, I’m here to share an impressive medical diagnostic stock with you [...]